ChestView US (1.1)
Gleamer · Decision date Sep 9, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 9, 2026 for ChestView US (1.1), a Gleamer radiological computer-assisted detection software device (21 CFR 892.2070, Class II, product code MYN, radiology panel). The submission is a traditional 510(k), K252486, with a Predetermined Change Control Plan authorized; the listed predicate is ChestView US, K241620. SESE is a clearance to market, not premarket approval. The public record shows a received date of 08/07/2025 on the database page, while the clearance letter cites August 10, 2026 for dating and receipt; the discrepancy is unresolved in the public information.
The summary describes software that marks regions of interest on frontal and lateral chest radiographs as Nodule, Consolidation, Pleural Space Abnormality, or Mediastinum/Hila Abnormality, with bounding-box styling tied to algorithm confidence, and states it is a concurrent reading aid for radiologists and emergency medicine physicians, prescription-only and for adults. The changed item is the model version relative to predicate 1.0. The summary states a modified model is deployed only if it meets all comparison non-inferiority criteria against both comparators and all primary-endpoint standalone criteria. Standalone performance results, the specific model changes, and the authorized change-control plan contents are not provided in the supplied excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 9, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K252486
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Gleamer
- Product code
- MYN
- Decision code
- SESE
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Analyzer, Medical Image.
FDA decision timeline
K252486 received
Application receipt date recorded by FDA.
K252486 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
DS Core DetectK261072 | Dentsply Sirona, Inc. | 510(k) clearance | Oct 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Gleamer
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Paris
Sources and methodology
- Original FDA record: K252486
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records